Adlai Nortye Ltd. Sponsored ADR

ANL Healthcare Biotechnology

Adlai Nortye Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.0 million, roughly unchanged from fiscal 2023. Dividend growth for five consecutive years.

11.07 1.02 −8.44%
Market cap
$710.1M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
−22.05
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Total current assets
124.54 66.30 101.20 64.06 26.89
Total non-current assets
7.14 6.29 28.99 7.21 7.54
Total Assets
131.69 72.59 130.19 71.27 34.43
Total current liabilities
17.50 312.65 49.67 45.36 41.63
Total non-current liabilities
299.62 1.24 5.47 0.43 1.13
Total liabilities
317.11 313.89 55.14 45.79 42.76
Common Equity (Total)
(196.41) (252.27) 75.05 25.49 (8.32)
Shareholders Equity (Total)
(185.43) (241.29) 75.05 25.49 (8.32)
Total Debt
12.51 5.54 30.83 26.76 25.71

Show all line items

In millions of $ except per-share values · columns are period end dates